Skip to main content

Advertisement

Log in

Human Papillomavirus-Mediated Cervical Cancer Awareness and Gardasil Vaccination: A Pilot Survey Among North Indian Women

  • Original Paper
  • Published:
Journal of Community Health Aims and scope Submit manuscript

Abstract

Human Papillomavirus (HPV)-mediated cervical cancer is a leading cause of morbidity and mortality in women worldwide, including Indian women. Cervical cancer control and prevention strategies are being adopted in developing nations to reduce the increasing burden of HPV infection in the vaccine era. The present study, therefore, aimed to evaluate cervical cancer awareness and knowledge of Gardasil vaccination in North Indian women. A pilot survey was conducted among 103 women of North Indian ethnicity residing in Lucknow/adjoining areas in state of Uttar Pradesh, during routine screening/clinic visits from June 2012 to December 2012. The study subjects were interviewed in either Hindi or English; subsequently the awareness of HPV-mediated cervical cancer and knowledge of Gardasil vaccination was assessed in terms of “yes”, “no” and “no response”. The study was approved by the Institutional Review Board. Written informed consent was taken from the participants. Overall, the response of participants (n = 103) in our single-centre survey-based pilot study was well-defined. The response regarding HPV-mediated cervical cancer awareness in terms of “yes”, “no” and “no response” among the study subjects was 43.7, 44.7 and 11.6 %, respectively. Furthermore, in response to knowledge of HPV vaccine Gardasil, out of 103 subjects, 28.1 % answered “yes” while 37.9 and 34.0 % stated “no” and “no response”, respectively. Our pilot survey may help in assessing knowledge of HPV-mediated cervical cancer and Gardasil vaccination awareness in women, and accordingly develop cost-effective cervical cancer control and prevention/public health counseling sessions in a clinical setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Pandey, S., Mittal, R. D., Srivastava, M., Srivastava, K., & Mittal, B. (2010). Cyclooxygenase-2 gene polymorphisms and risk of cervical cancer in North Indian population. IJGC, 20, 625–630.

    Google Scholar 

  2. Vizcaino, A. P., Moreno, V., Bosch, F. X., et al. (2000). International trends in incidence of cervical cancer: II. Squamous—Cell carcinoma. International Journal of Cancer, 86, 429–435.

    Article  CAS  Google Scholar 

  3. Walboomers, J. M., Jacobs, M. V., Manos, M. M., et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189, 12–19.

    Article  PubMed  CAS  Google Scholar 

  4. Zur Hausen, H. (2002). Papillomaviruses and cervical cancer. Nature Reviews, 2, 342–350.

    Article  PubMed  CAS  Google Scholar 

  5. Bosch, F. X., Lorincz, A., Munoz, N., et al. (2002). The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology, 55, 244–265.

    Article  PubMed  CAS  Google Scholar 

  6. Ferlay, J., Bray, F., Pisani, P., Parkin, D. M., & GLOBOCAN 2002. (2004). Cancer incidence, mortality and prevalence worldwide, version 2.0. IARC Cancer Base No. 5 Lyon. France: IARC Press.

  7. Dabash, R., Vajpayee, J., Jacob, M., et al. (2005). A strategic assessment of cervical cancer prevention and treatment services in 3 districts of Uttar Pradesh, India. Reproductive Health, 2, 11.

    Article  PubMed  Google Scholar 

  8. Pandey, S., Mishra, M., & Chandrawati, (2012). Human Papillomavirus screening in North Indian women. APJCP, 13, 4867–4871.

    PubMed  Google Scholar 

  9. Motoyama, S., Ladines-Llave, C. A., Luis Villanueva, S., & Maruo, T. (2004). The role of human papillomavirus in the molecular biology of cervical carcinogenesis. Kobe Journal of Medical Sciences, 50, 9–19.

    PubMed  CAS  Google Scholar 

  10. Li, T. T., Zhao, L. N., Liu, Z. G., Han, Y., & Fan, D. M. (2005). Regulation of apoptosis by the papillomavirus E6 oncogene. World Journal of Gastroenterology, 11, 931–937.

    PubMed  CAS  Google Scholar 

  11. Miller, A. B. (1992). Cervical cancer screening programmes: Managerial guidelines. Geneva: World Health Organization.

    Google Scholar 

  12. Solomon, D., Schiffman, M., & Tarone, R. (2001). Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. Journal of the National Cancer Institute, 93, 293–299.

    Article  PubMed  CAS  Google Scholar 

  13. Bovicelli, A., Bristow, R. E., & Montz, F. J. (2000). HPV testing: Where are we now? Anticancer Research, 20, 4673–4680.

    PubMed  CAS  Google Scholar 

  14. Villa, L. L., Costa, R. L., Pettac, A., et al. (2005). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncology, 6, 271–278.

    Article  PubMed  Google Scholar 

  15. Villa, L. L., Ault, K. A., Guiliano, A. R., et al. (2006). Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine, 24, 5571–5583.

    Article  PubMed  CAS  Google Scholar 

  16. Harper, D. M., Franco, E. L., Wheeler, C., et al. (2006). Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomized control trial. Lancet, 367, 1247–1255.

    Article  PubMed  CAS  Google Scholar 

  17. Harper, D. M., Franco, E. L., Wheeler, C., et al. (2004). Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial. Lancet, 364, 1757–1765.

    Article  PubMed  CAS  Google Scholar 

  18. Villa, L. L., Costa, R. L. R., Petta, C. A., et al. (2007). High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus like particle vaccine through 5 years follow-up. British Journal of Cancer, 6, 1459–1466.

    Google Scholar 

  19. Bharadwaj, M., Hussain, S., Nasare, V., & Das, B. C. (2009). HPV & HPV vaccination: Issues in developing countries. Indian Journal of Medical Research, 130, 327–333.

    PubMed  Google Scholar 

  20. International Agency for Research on Cancer. (2005). IARC Handbooks of Cancer Prevention. Cervix Cancer Screening. Lyon: IARC Press.

    Google Scholar 

  21. Kjaer, S. K., Sigurdsson, K., Iversen, O. E., et al. (2009). A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions. Cancer Prevention Research (Phila), 2, 868–878.

    Article  Google Scholar 

  22. Paavonen, J., Naud, P., Salmeron, J., et al. (2009). Efficacy of human papillomavirus (HPV)-16/18 ASO4-adjuvanated vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomized study in young women. Lancet, 374, 301–314.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We acknowledge the assistance provided by the support/clinical staff of Krishna Medical Centre, Lucknow during the survey-based study.

Conflict of interest

The authors state no conflict of interest and have not received any payment in preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Saumya Pandey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pandey, S., Chandravati Human Papillomavirus-Mediated Cervical Cancer Awareness and Gardasil Vaccination: A Pilot Survey Among North Indian Women. J Community Health 38, 907–910 (2013). https://doi.org/10.1007/s10900-013-9697-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-013-9697-6

Keywords

Navigation